Oscient Pharmaceuticals Corporation (OSCI) Acquires Expanded Worldwide Rights To Lead Clinical Candidate Ramoplanin
2/8/2006 10:41:13 AM
More...
|
East Bay Biotechs Hit Sales Block
1/3/2006 11:44:06 AM
More...
|
Vicuron Pharmaceuticals, Inc. (MICU) Extends Pfizer Inc. (PFE) Deal To Develop Oral Antibiotics For Community Market
10/19/2005 5:13:10 PM
More...
|
Vicuron Pharmaceuticals, Inc. (MICU) Announces Fourth Quarter 2004 Financial Results
10/19/2005 5:12:59 PM
More...
|
Vicuron Pharmaceuticals, Inc. (MICU) To Present At The SG Cowen & Co., LLC 25th Annual Health Care Conference
10/19/2005 5:12:59 PM
More...
|
Vicuron Pharmaceuticals, Inc. (MICU) Provides Update On Novartis Pharma AG (NVS) Peptide Deformylase Inhibitor Program; Suspension Of Phase I First Lead Candidate In Favor Of Second Compound
10/19/2005 5:12:55 PM
More...
|
Vicuron Pharmaceuticals, Inc. (MICU) To Present At The Wells Fargo Securities Healthcare Conference
10/19/2005 5:12:51 PM
More...
|
Vicuron Pharmaceuticals, Inc. (MICU) Granted Priority Review Of Dalbavancin NDA By FDA In Complicated Skin And Soft Tissue Infections
10/19/2005 5:12:49 PM
More...
|
Vicuron Pharmaceuticals, Inc. (MICU) To Present At The Biotechnology Industry Organization (BIO) CEO & Investor Conference 2005
10/19/2005 5:12:45 PM
More...
|
The Day In Review: Biotech Consolidates After Recent Gains
10/19/2005 5:12:38 PM
More...
|
|